Lineage Cell Therapeutics Inc Earnings

The next earnings date for Lineage Cell Therapeutics Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Lineage Cell Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-0.02

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Lineage Cell Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/12/2025	---	$-0.13	-379.70%
05/07/2025	Before Market	$-0.02	28.57%
03/05/2025	Before Market	$-0.01	66.67%
11/07/2024	Before Market	$-0.02	50.00%
08/08/2024	After Market	$-0.03	40.00%
05/09/2024	After Market	$-0.04	0.00%
03/07/2024	After Market	$-0.03	25.00%
11/09/2023	After Market	$-0.04	0.00%
08/10/2023	After Market	$-0.03	25.00%
05/11/2023	After Market	$-0.03	25.00%
03/09/2023	After Market	$-0.03	25.00%
11/10/2022	After Market	$-0.04	0.00%
08/11/2022	After Market	$-0.04	0.00%
05/12/2022	After Market	$-0.04	-33.33%
03/10/2022	After Market	$-0.17	-240.00%
11/10/2021	After Market	$-0.05	0.00%
08/12/2021	After Market	$-0.03	25.00%
05/13/2021	After Market	$-0.01	75.00%
03/11/2021	After Market	$0.01	120.00%
11/04/2020	After Market	$-0.05	-25.00%
08/06/2020	After Market	$-0.04	0.00%
05/07/2020	After Market	$-0.06	-20.00%
03/12/2020	After Market	$-0.03	40.00%
11/12/2019	After Market	$-0.12	-140.00%
08/08/2019	After Market	$-0.20	-300.00%
05/09/2019	After Market	$0.30	600.00%
03/14/2019	After Market	$-0.32	-357.14%
11/08/2018	Before Market	$-0.09	-28.57%
08/02/2018	After Market	$-0.03	57.14%
05/10/2018	After Market	$-0.50	-614.29%
03/15/2018	After Market	$-0.58	-728.57%
11/09/2017	After Market	$0.12	250.00%
08/02/2017	After Market	$-0.11	-37.50%
05/10/2017	After Market	$0.46	611.11%
03/16/2017	After Market	$-0.05	64.29%
11/03/2016	After Market	$0.30	314.29%
08/09/2016	After Market	$-0.11	35.29%
05/10/2016	After Market	$-0.19	-35.71%
03/15/2016	After Market	$-0.16	5.88%
11/09/2015	Before Market	$-0.18	---
08/10/2015	After Market	$-0.12	---
05/08/2015	After Market	$-0.13	---
03/11/2015	Before Market	$-0.14	---
11/07/2014	After Market	$-0.12	---
08/04/2014	---	$-0.16	---
05/12/2014	---	$-0.14	---
03/24/2014	---	$-0.35	---
11/13/2013	---	$-0.16	---
08/12/2013	---	$-0.14	---
05/13/2013	---	$-0.15	---
03/19/2013	---	$-0.12	---
11/12/2012	---	$-0.10	---
08/10/2012	---	$-0.11	---
05/09/2012	---	$-0.10	---
03/15/2012	---	$-0.11	---
11/09/2011	---	$-0.08	---
08/10/2011	---	$-0.09	---
05/05/2011	---	$-0.07	---
03/09/2011	---	$-0.06	---
11/15/2010	---	$-0.11	---
08/17/2010	---	$-0.06	---
05/05/2010	---	$-0.04	---
03/10/2010	---	$0.06	---
11/24/2009	---	$-0.11	---
08/14/2009	---	$-0.05	---
05/19/2009	---	$-0.06	---
03/30/2009	---	$-0.07	---
11/21/2008	---	$-0.05	---
08/15/2008	---	$-0.03	---
05/20/2008	---	$-0.02	---
11/15/2007	---	$-0.01	---
08/16/2007	---	$-0.02	---
05/16/2007	---	$-0.02	---
11/15/2006	---	$-0.02	---
08/16/2006	---	$-0.03	-50.00%
04/18/2006	---	$-0.03	---
11/15/2005	---	$-0.02	50.00%
08/15/2005	---	$-0.02	50.00%
05/17/2005	---	$-0.04	---
11/16/2004	---	$-0.03	---
08/13/2004	---	$-0.02	---
05/17/2004	---	$-0.10	---
03/29/2004	---	$-0.04	---
11/12/2003	---	$0.03	---
08/13/2003	---	$-0.06	---
08/15/1998	---	$-0.08	20.00%
06/24/1998	---	$-0.11	0.00%
03/19/1998	---	$-0.06	40.00%
10/08/1997	---	$-0.12	-400.00%
07/08/1997	---	$-0.06	0.00%
02/20/1997	---	$-0.07	-16.67%

More About Lineage Cell Therapeutics Inc

Website

https://www.lineagecell.com

Country

USA

Full Time Employees

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries; and VAC2, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of sensorineural hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company is developing RND1, a cell transplant program for an undisclosed indication through a gene editing collaboration, engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Immunomic Therapeutics, Inc., for the treatment of glioblastoma multiforme. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

“Lineage Cell Therapeutics Inc Earnings” Can Refer to the Lineage Cell Therapeutics Inc Earnings Date

Some people say “Lineage Cell Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Lineage Cell Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Lineage Cell Therapeutics Inc Stock on the Earnings Date

If you own Lineage Cell Therapeutics Inc stock (LCTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Lineage Cell Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Lineage Cell Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Lineage Cell Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Lineage Cell Therapeutics Inc earnings or anything else related to the stock market.